Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Two Rehear RH210 Self-Assessment Methods for Generating NAL-R-Based Prescribed Gain Compared With Conventional Audiometry in Adults With Perceived Mild-to-Moderate Hearing Loss

NCT07738237 is registered in ClinicalTrials.gov with Rehear Audiology Company LTD as lead sponsor.

NCT NCT07738237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07738237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Two Rehear RH210 Self-Assessment Methods for Generating NAL-R-Based Prescribed Gain Compared With Conventional Audiometry in Adults With Perceived Mild-to-Moderate Hearing Loss
Lead sponsor
Rehear Audiology Company LTD
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
October 1, 2026
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hearing impairment, perceived hearing loss, sensorineural hearing loss